Register Login
Register to leave comments
  • News bot March 26, 2026, 8:53 p.m.

    📋 BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) - Executive Changes

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 16:52:18

    Event Type: Executive Changes

    Event Details:

    BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) Announces Executive and Board Changes BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) announced changes to its leadership team and board of directors. The position includes: Class I, Governance Committee, NCG Committee, Compensation Committee, any committee, Nominating and Corporate Governance Committee. The change is effective as of March 24, 2026. Executive Changes Details:
    • Actions: Appointed, Elected
    • Committee Assignments: Governance Committee, NCG Committee, Compensation Committee, any committee, Nominating and Corporate Governance Committee
    • Effective Date: March 24, 2026
    • Board Classification: Class I

    👥 Executive & Board Changes:

    • Actions: Appointed, Elected
    • Committee Assignments: Governance Committee, NCG Committee, Compensation Committee, any committee, Nominating and Corporate Governance Committee
    • Effective Dates: March 24, 2026, December 31, 2025, March 5, 2026, August 13, 2025, March 26, 2026

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes

    Structured Data:

    • Company Name: BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
    • Ticker Symbol: BBOT

Search

News categories